We also examined the mTOR pathway, which is downstream of PI3K, not only because it is dysregulated in HPV+ HNSCC but also because mTOR inhibitors show promising anticancer effects in HPV+ HNSCC mouse models (75). The gene discussed is PIK3CA; the disease is head and neck squamous cell carcinoma.